Elevated PIK3CA protein activity in AR+ TNBC (through amplification and mutation) will bypass the AR-mediated PTEN up-regulation so that targeting AR alone may promote tumor growth by lowering PTEN expression and motivating the PI3K pathway. The gene discussed is PTEN; the disease is neoplasm.